The stratum corneum: The rampart of the mammalian body

Veterinary Dermatology

Volumn 24, Issue 1, 2013, Pages

  Nishifuji, Koji ^a   Yoon, Ji Seon ^b  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; EPIDERMIS; GENE EXPRESSION REGULATION; HISTOLOGY; HUMAN; MAMMAL; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN DISEASE;

ANIMALS; EPIDERMIS; GENE EXPRESSION REGULATION; HUMANS; MAMMALS; SKIN DISEASES;

BOS; CANIS FAMILIARIS; MAMMALIA; MUS;

EID: 84872702813     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2012.01090.x     Document Type: Article

References (148)

1. Elias PM. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol 1983; 80: 44s-49s.
2. Steinert PM, Cantieri JS, Teller DC et al. Characterization of a class of cationic proteins that specifically interact with intermediate filaments. Proc Natl Acad Sci USA 1981; 78: 4097-4101.
3. Kawasaki H, Kubo A, Sasaki T et al. Loss-of-function mutations within the filaggrin gene and atopic dermatitis. Curr Probl Dermatol 2011; 41: 35-46.
4. Sandilands A, Sutherland C, Irvine AD et al. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009; 122: 1285-1294.
5. Dale BA, Resing KA, Lonsdale-Eccles JD. Filaggrin: a keratin filament associated protein. Ann N Y Acad Sci 1985; 455: 330-342.
6. Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Exp Mol Med 1999; 31: 5-19.
7. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328-340.
8. Swartzendruber DC, Wertz PW, Madison KC et al. Evidence that the corneocyte has a chemically bound lipid envelope. J Invest Dermatol 1987; 88: 709-713.
9. Swartzendruber DC, Wertz PW, Kitko DJ et al. Molecular models of the intercellular lipid lamellae in mammalian stratum corneum. J Invest Dermatol 1989; 92: 251-257.
10. Chapman SJ, Walsh A. Desmosomes, corneosomes and desquamation. An ultrastructural study of adult pig epidermis. Arch Dermatol Res 1990; 282: 304-310.
11. Serre G, Mils V, Haftek M et al. Identification of late differentiation antigens of human cornified epithelia, expressed in re-organized desmosomes and bound to cross-linked envelope. J Invest Dermatol 1991; 97: 1061-1072.
12. Skerrow CJ, Clelland DG, Skerrow D. Changes to desmosomal antigens and lectin-binding sites during differentiation in normal human epidermis: a quantitative ultrastructural study. J Cell Sci 1989; 92: 667-677.
13. Shimizu H. Structure and Function of the Skin. In: Shimizu's Textbook of Dermatology. 1st edition. Tokyo: Nakayama Shoten, 2007; 1-26.
14. McGowan KA, Aradhya S, Fuchs H et al. A mouse keratin1 mutation causes dark skin and epidermolytic hyperkeratosis. J Invest Dermatol 2006; 126: 1013-1016.
15. Bickenbach JR, Longley MA, Bundman DS et al. A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosis. Differentiation 1996; 61: 129-139.
16. Reichelt J, Bauer C, Porter R et al. Out of balance: consequences of a partial keratin10 knockout. J Cell Sci 1997; 110: 2175-2186.
17. Arin MJ, Longley MA, Wang XJ et al. Focal activation of a mutant allele defines the role of stem cells in mosaic skin disorders. J Cell Biol 2001; 152: 645-649.
18. Porter RM, Leitgeb S, Melton DW et al. Gene targeting at the mouse cytokeratin10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis. J Cell Biol 1996; 132: 925-936.
19. Fitch KR, McGowan KA, van Raamsdonk CD et al. Genetics of dark skin in mice. Genes Dev 2003; 17: 214-228.
20. Nemoto-Hasebe I, Akiyama M, Nomura T et al. FLG mutation p.Lys4021X in the C-terminal imperfect filaggrin repeat in Japanese patients with atopic eczema. Br J Dermatol 2009; 161: 1387-1390.
21. Sandilands A, Terron-Kwiatkowski A, Hull PR et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007; 39: 650-654.
22. Gan SQ, McBride OW, Idler WW et al. Organization, structure, and polymorphisms of the human profilaggrin gene. Biochemistry 1990; 29: 9432-9440.
23. McKinley-Grant LJ, Idler WW, Bernstein IA et al. Characterization of a cDNA clone encoding human filaggrin and localization of the gene to chromosome region 1q21. Proc Natl Acad Sci USA 1989; 86: 4848-4852.
24. Presland RB, Haydock PV, Fleckman P et al. Characterization of the human epidermal profilaggrin gene. Genomic organization and identification of an S-100-like calcium binding domain at the amino terminus. J Biol Chem 1992; 267: 23772-23781.
25. Rothnagel JA, Steinert PM. The structure of the gene for mouse filaggrin and a comparison of the repeating units. J Biol Chem 1990; 265: 1862-1865.
26. Zhang D, Karunaratne S, Kessler M et al. Characterization of mouse profilaggrin: evidence for nuclear engulfment and translocation of the profilaggrin B-domain during epidermal differentiation. J Invest Dermatol 2002; 119: 905-912.
27. Fallon PG, Sasaki T, Sandilands A et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009; 41: 602-608.
28. Hoste E, Kemperman P, Devos M et al. Caspase-14 is required for filaggrin degradation to natural moisturizing factors in the skin. J Invest Dermatol 2011; 131: 2233-2241.
29. Denecker G, Hoste E, Gilbert B et al. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 2007; 9: 666-674.
30. Presland RB, Boggess D, Lewis SP et al. Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol 2000; 115: 1072-1081.
31. Moniaga CS, Egawa G, Kawasaki H et al. Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract. Am J Pathol 2010; 176: 2385-2393.
32. Kawasaki H, Nagao K, Kubo A et al. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. J Allergy Clin Immunol 2012; 129: 1538-1546.
33. Kubo A, Nagao K, Yokouchi M et al. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 2009; 206: 2937-2946.
34. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol 2008; 17: 1063-1072.
35. Akiyama M. Updated molecular genetics and pathogenesis of ichthiyoses. Nagoya J Med Sci 2011; 73: 79-90.
36. Kim IG, McBride OW, Wang M et al. Structure and organization of the human transglutaminase1 gene. J Biol Chem 1992; 267: 7710-7717.
37. Yamanishi K, Inazawa J, Liew FM et al. Structure of the gene for human transglutaminase1. J Biol Chem 1992; 267: 17858-17863.
38. Egberts F, Heinrich M, Jensen JM et al. CathepsinD is involved in the regulation of transglutaminase1 and epidermal differentiation. J Cell Sci 2004; 117: 2295-2307.
39. Koch PJ, de Viragh PA, Scharer E et al. Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol 2000; 151: 389-400.
40. Djian P, Easley K, Green H. Targeted ablation of the murine involucrin gene. J Cell Biol 2000; 151: 381-388.
41. Sevilla LM, Nachat R, Groot KR et al. Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier. J Cell Biol 2007; 179: 1599-1612.
42. Ishida-Yamamoto A, Kishibe M. Involvement of corneodesmosome degradation and lamellar granule transportation in the desquamation process. Med Mol Morphol 2011; 44: 1-6.
43. Suzuki Y, Koyama J, Moro O et al. The role of two endogenous proteases of the stratum corneum in degradation of desmoglein-1 and their reduced activity in the skin of ichthyotic patients. Br J Dermatol 1996; 134: 460-464.
44. Simon M, Montezin M, Guerrin M et al. Characterization and purification of human corneodesmosin, an epidermal basic glycoprotein associated with corneocyte-specific modified desmosomes. J Biol Chem 1997; 272: 31770-31776.
45. Caubet C, Jonca N, Brattsand M et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 2004; 122: 1235-1244.
46. Descargues P, Deraison C, Prost C et al. Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome. J Invest Dermatol 2006; 126: 1622-1632.
47. Simon M, Jonca N, Guerrin M et al. Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J Biol Chem 2001; 276: 20292-20299.
48. Bernard D, Méhul B, Thomas-Collignon A et al. Analysis of proteins with caseinolytic activity in a human stratum corneum extract revealed a yet unidentified cysteine protease and identified the so-called "stratum corneum thiol protease" as cathepsinL2. J Invest Dermatol 2003; 120: 592-600.
49. Igarashi S, Takizawa T, Takizawa T et al. CathepsinD, but not cathepsinE, degrades desmosomes during epidermal desquamation. Br J Dermatol 2004; 151: 355-361.
50. Brattsand M, Stefansson K, Lundh C et al. A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol 2005; 124: 198-203.
51. Lundwall A, Brattsand M. Kallikrein-related peptidases. Cell Mol Life Sci 2008; 65: 2019-2038.
52. Sotiropoulou G, Pampalakis G, Diamandis EP. Functional roles of human kallikrein-related peptidases. J Biol Chem 2009; 284: 32989-32994.
53. Borgono CA, Michael IP, Komatsu N et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 2007; 282: 3640-3652.
54. Komatsu N, Tsai B, Sidiropoulos M et al. Quantification of eight tissue kallikreins in the stratum corneum and sweat. J Invest Dermatol 2006; 126: 925-929.
55. Magert HJ, Standker L, Kreutzmann P et al. LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem 1999; 274: 21499-21502.
56. Deraison C, Bonnart C, Lopez F et al. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol Cell 2007; 18: 3607-3619.
57. Ishida-Yamamoto A, Deraison C, Bonnart C et al. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. J Invest Dermatol 2005; 124: 360-366.
58. Descargues P, Deraison C, Bonnart C et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein1 by epidermal protease hyperactivity. Nat Genet 2005; 37: 56-65.
59. Briot A, Deraison C, Lacroix M et al. Kallikrein5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 2009; 206: 1135-1147.
60. Downing DT, Stewart ME, Wertz PW et al. Skin lipids: an update. J Invest Dermatol 1987; 88: 2s-6s.
61. Feingold KR. Lipid metabolism in the epidermis. Dermatoendocrinology 2011; 3: 52.
62. Epp N, Fürstenberger G, Müller K et al. 12R-lipoxygenase deficiency disrupts epidermal barrier function. J Cell Biol 2007; 177: 173-182.
63. Moran JL, Qiu H, Turbe-Doan A et al. A mouse mutation in the 12R-lipoxygenase, Alox12b, disrupts formation of the epidermal permeability barrier. J Invest Dermatol 2007; 127: 1893-1897.
64. Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta 2006; 1758: 2080-2095.
65. Marekov LN, Steinert PM. Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J Biol Chem 1998; 273: 17763-17770.
66. Jungersted JM, Hellgren LI, Jemec GB et al. Lipids and skin barrier function - a clinical perspective. Contact Dermatitis 2008; 58: 255-262.
67. Holleran WM, Man MQ, Gao WN et al. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest 1991; 88: 1338-1345.
68. Coderch L, López O, de la Maza A et al. Ceramides and skin function. Am J Clin Dermatol 2003; 4: 107-129.
69. Mizutani Y, Mitsutake S, Tsuji K et al. Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie 2009; 91: 784-790.
70. Uchida Y, Hara M, Nishio H et al. Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 2000; 41: 2071-2082.
71. Holleran WM, Takagi Y, Menon GK et al. Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 1993; 91: 1656-1664.
72. Holleran WM, Ginns EI, Menon GK et al. Consequences of β-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest 1994; 93: 1756-1764.
73. Hamanaka S, Hara M, Nishio H et al. Human epidermal glucosylceramides are major precursors of stratum corneum ceramides. J Invest Dermatol 2002; 119: 416-423.
74. Doering T, Proia RL, Sandhoff K. Accumulation of protein-bound epidermal glucosylceramides in β-glucocerebrosidase deficient type2 Gaucher mice. FEBS Lett 1999; 447: 167-170.
75. Mitsutake S, Suzuki C, Akiyama M et al. ABCA12 dysfunction causes a disorder in glucosylceramide accumulation during keratinocyte differentiation. J Dermatol Sci 2010; 60: 128-129.
76. Yanagi T, Akiyama M, Nishihara H et al. Harlequin ichthyosis model mouse reveals alveolar collapse and severe fetal skin barrier defects. Hum Mol Genet 2008; 17: 3075-3083.
77. Farwanah H, Wohlrab J, Neubert RH et al. Profiling of human stratum corneum ceramides by means of normal phase LC/APCI-MS. Anal Bioanal Chem 2005; 383: 632-637.
78. Ponec M, Weerheim A, Lankhorst P et al. New acylceramide in native and reconstructed epidermis. J Invest Dermatol 2003; 120: 581-588.
79. Masukawa Y, Narita H, Sato H et al. Comprehensive quantification of ceramide species in human stratum corneum. J Lipid Res 2009; 50: 1708-1719.
80. Yoon JS, Nishifuji K, Sasaki A et al. Alteration of stratum corneum ceramide profiles in spontaneous canine model of atopic dermatitis. Exp Dermatol 2011; 20: 732-736.
81. Uchida Y, Holleran WM. Omega-O-acylceramide, a lipid essential for mammalian survival. J Dermatol Sci 2008; 51: 77-87.
82. Bouwstra JA, Gooris GS, Dubbelaar FE et al. Role of ceramide1 in the molecular organization of the stratum corneum lipids. J Lipid Res 1998; 39: 186-196.
83. de Jager M, Gooris G, Ponec M et al. Acylceramide head group architecture affects lipid organization in synthetic ceramide mixtures. J Invest Dermatol 2004; 123: 911-916.
84. Behne M, Uchida Y, Seki T et al. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol 2000; 114: 185-192.
85. Farwanah H, Pierstorff B, Schmelzer CE et al. Separation and mass spectrometric characterization of covalently bound skin ceramides using LC/APCI-MS and Nano-ESI-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 852: 562-570.
86. Popa I, Thuy LH, Colsch B et al. Analysis of free and protein-bound ceramides by tape stripping of stratum corneum from dogs. Arch Dermatol Res 2010; 302: 639-644.
87. Herzinger T, Kleuser B, Schäfer-Korting M et al. Sphingosine-1-phosphate signaling and the skin. Am J Clin Dermatol 2007; 8: 329-336.
88. Baumer W, Rossbach K, Mischke R et al. Decreased concentration and enhanced metabolism of sphingosine-1-phosphate in lesional skin of dogs with atopic dermatitis: disturbed sphingosine-1-phosphate homeostasis in atopic dermatitis. J Invest Dermatol 2011; 131: 266-268.
89. Moulson CL, Martin DR, Lugus JJ et al. Cloning of wrinkle-free, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein4 in skin and hair development. Proc Natl Acad Sci USA 2003; 100: 5274-5279.
90. Herrmann T, van der Hoeven F, Grone HJ et al. Mice with targeted disruption of the fatty acid transport protein 4 (Fatp 4, Slc27a4) gene show features of lethal restrictive dermopathy. J Cell Biol 2003; 161: 1105-1115.
91. Akiyama M, Sugiyama-Nakagiri Y, Sakai K et al. Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J Clin Invest 2005; 115: 1777-1784.
92. Russell LJ, DiGiovanna JJ, Rogers GR et al. Mutations in the gene for transglutaminase1 in autosomal recessive lamellar ichthyosis. Nat Genet 1995; 9: 279-283.
93. Parmentier L, Blanchet-Bardon C, Nguyen S et al. Autosomal recessive lamellar ichthyosis: identification of a new mutation in transglutaminase1 and evidence for genetic heterogeneity. Hum Mol Genet 1995; 4: 1391-1395.
94. Laiho E, Ignatius J, Mikkola H et al. Transglutaminase1 mutations in autosomal recessive congenital ichthyosis: private and recurrent mutations in an isolated population. Am J Hum Genet 1997; 61: 529-538.
95. Akiyama M, Takizawa Y, Kokaji T et al. Novel mutations of TGM1 in a child with congenital ichthyosiform erythroderma. Br J Dermatol 2001; 144: 401-407.
96. Lefevre C, Audebert S, Jobard F et al. Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type2. Hum Mol Genet 2003; 12: 2369-2378.
97. Jobard F, Lefèvre C, Karaduman A et al. Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1. Hum Mol Genet 2002; 11: 107-113.
98. Lefèvre C, Bouadjar B, Karaduman A et al. Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis. Hum Mol Genet 2004; 13: 2473-2482.
99. Lefèvre C, Bouadjar B, Ferrand V et al. Mutations in a new cytochrome P450 gene in lamellar ichthyosis type3. Hum Mol Genet 2006; 15: 767-776.
100. Cheng J, Syder AJ, Yu QC et al. The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell 1992; 70: 811-819.
101. Rothnagel JA, Dominey AM, Dempsey LD et al. Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science 1992; 257: 1128-1130.
102. Chipev CC, Korge BP, Markova N et al. A leucine→proline mutation in the H1 subdomain of keratin1 causes epidermolytic hyperkeratosis. Cell 1992; 70: 821-828.
103. Koppe G, Marinković-Ilsen A, Rijken Y et al. X-linked icthyosis. A sulphatase deficiency. Arch Dis Child 1978; 53: 803-806.
104. Webster D, France JT, Shapiro LJ et al. X-linked ichthyosis due to steroid-sulphatase deficiency. Lancet 1978; 1(8055): 70-72.
105. Arin MJ, Longley MA, Epstein EH Jr et al. A novel mutation in the 1A domain of keratin2e in ichthyosis bullosa of Siemens. J Invest Dermatol 1999; 112: 380-382.
106. Suga Y, Arin MJ, Scott G et al. Hot spot mutations in keratin2e suggest a correlation between genotype and phenotype in patients with ichthyosis bullosa of Siemens. Exp Dermatol 2000; 9: 11-15.
107. Smith FJ, Irvine AD, Terron-Kwiatkowski A et al. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006; 38: 337-342.
108. Klar J, Schweiger M, Zimmerman R et al. Mutations in the fatty acid transport protein4 gene cause the ichthyosis prematurity syndrome. Am J Hum Genet 2009; 85: 248-253.
109. Chavanas S, Bodemer C, Rochat A et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000; 25: 141-142.
110. Badeloe S, van Geel M, Nagtzaam I et al. Chanarin-Dorfman syndrome caused by a novel splice site mutation in ABHD5. Br J Dermatol 2008; 158: 1378-1380.
111. Molteni L, Dardano S, Parma P et al. Ichthyosis in Chianina cattle. Vet Rec 2006; 158: 412-414.
112. Charlier C, Coppieters W, Rollin F et al. Highly effective SNP-based association mapping and management of recessive defects in livestock. Nat Genet 2008; 40: 449-454.
113. Credille KM, Minor JS, Barnhart KF et al. Transglutaminase1-deficient recessive lamellar ichthyosis associated with a LINE-1 insertion in Jack Russell terrier dogs. Br J Dermatol 2009; 161: 265-272.
114. Grall A, Guaguère E, Planchais S et al. PNPLA1 mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans. Nat Genet 2012; 44: 140-147.
115. Credille KM, Barnhart KF, Minor JS et al. Mild recessive epidermolytic hyperkeratosis associated with a novel keratin10 donor splice-site mutation in a family of Norfolk terrier dogs. Br J Dermatol 2005; 153: 51-58.
116. Janssens M, van Smeden J, Gooris GS et al. Lamellar lipid organization and ceramide composition in the stratum corneum of patients with atopic eczema. J Invest Dermatol 2011; 131: 2136-2138.
117. Imokawa G, Abe A, Jin K et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991; 96: 523-526.
118. Di Nardo A, Wertz P, Giannetti A et al. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998; 78: 27-30.
119. Ishikawa J, Narita H, Kondo N et al. Changes in the ceramide profile of atopic dermatitis patients. J Invest Dermatol 2010; 130: 2511-2514.
120. Macheleidt O, Kaiser HW, Sandhoff K. Deficiency of epidermal protein-bound ω-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002; 119: 166-173.
121. Jensen JM, Fölster-Holst R, Baranowsky A et al. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004; 122: 1423-1431.
122. Hara J, Higuchi K, Okamoto R et al. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 2000; 115: 406-413.
123. Imokawa G. A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. J Dermatol Sci 2009; 55: 1-9.
124. Murata Y, Ogata J, Higaki Y et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 1996; 106: 1242-1249.
125. Seo EY, Park GT, Lee KM et al. Identification of the target genes of atopic dermatitis by real-time PCR. J Invest Dermatol 2006; 126: 1187-1189.
126. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-446.
127. Vasilopoulos Y, Cork MJ, Murphy R et al. Genetic association between an AACC insertion in the 3′UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 2004; 123: 62-66.
128. Komatsu N, Saijoh K, Kuk C et al. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients. Exp Dermatol 2007; 16: 513-519.
129. Voegeli R, Rawlings AV, Breternitz M et al. Increased stratum corneum serine protease activity in acute eczematous atopic skin. Br J Dermatol 2009; 161: 70-77.
130. Inman AO, Olivry T, Dunston SM et al. Electron microscopic observations of stratum corneum intercellular lipids in normal and atopic dogs. Vet Pathol 2001; 38: 720-723.
131. Piekutowska A, Pin D, Rème CA et al. Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs. J Comp Pathol 2008; 138: 197-203.
132. Marsella R, Samuelson D, Doerr K. Transmission electron microscopy studies in an experimental model of canine atopic dermatitis. Vet Dermatol 2010; 21: 81-88.
133. Shimada K, Yoon JS, Yoshihara T et al. Increased transepidermal water loss and decreased ceramide content in lesional and non-lesional skin of dogs with atopic dermatitis. Vet Dermatol 2009; 20: 541-546.
134. Reiter LV, Torres SM, Wertz PW. Characterization and quantification of ceramides in the nonlesional skin of canine patients with atopic dermatitis compared with controls. Vet Dermatol 2009; 20: 260-266.
135. Popa I, Remoue N, Hoang LT et al. Atopic dermatitis in dogs is associated with a high heterogeneity in the distribution of protein-bound lipids within the stratum corneum. Arch Dermatol Res 2011; 303: 433-440.
136. Wood SH, Clements DN, Ollier WE et al. Gene expression in canine atopic dermatitis and correlation with clinical severity scores. J Dermatol Sci 2009; 55: 27-33.
137. Wood SH, Ollier WE, Nuttall T et al. Despite identifying some shared gene associations with human atopic dermatitis the use of multiple dog breeds from various locations limits detection of gene associations in canine atopic dermatitis. Vet Immunol Immunopathol 2010; 138: 193-197.
138. Barros Roque J, O'Leary CA, Kyaw-Tanner M et al. Haplotype sharing excludes canine orthologous Filaggrin locus in atopy in West Highland White Terriers. Anim Genet 2009; 40: 793-794.
139. Salzmann CA, Olivry TJ, Nielsen DM et al. Genome-wide linkage study of atopic dermatitis in West Highland White Terriers. BMC Genet 2011; 12: 37.
140. Marsella R, Samuelson D, Harrington L. Immunohistochemical evaluation of filaggrin polyclonal antibody in atopic and normal beagles. Vet Dermatol 2009; 20: 547-554.
141. Chervet L, Galichet A, McLean WH et al. Missing C-terminal filaggrin expression, NFkappaB activation and hyperproliferation identify the dog as a putative model to study epidermal dysfunction in atopic dermatitis. Exp Dermatol 2010; 19: e343-e346.
142. Carlsen BC, Johansen JD, Menne T et al. Filaggrin null mutations and association with contact allergy and allergic contact dermatitis: results from a tertiary dermatology clinic. Contact Dermatitis 2010; 63: 89-95.
143. Thyssen JP, Johansen JD, Linneberg A et al. The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population. Br J Dermatol 2010; 162: 1278-1285.
144. Novak N, Baurecht H, Schafer T et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008; 128: 1430-1435.
145. Betz RC, Pforr J, Flaquer A et al. Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J Invest Dermatol 2007; 127: 2539-2543.
146. Finn LS, Zhang M, Chen SH et al. Severe type II Gaucher disease with ichthyosis, arthrogryposis and neuronal apoptosis: molecular and pathological analyses. Am J Med Genet 2000; 91: 222-226.
147. Ishida Yamamoto A. Loricrin keratoderma: a novel disease entity characterized by nuclear accumulation of mutant loricrin. J Dermatol Sci 2003; 31: 3-8.
148. Ohnishi Y, Okino N, Ito M et al. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clin Diagn Lab Immunol 1999; 6: 101-104.